```html

Zygomycete Infection (Fungal Sinusitis) – Why It Can Cause Persistent Nasal Congestion

What is Zygomycete infection (fungal sinusitis) nasal congestion?

Zygomycete infection, also known as zygomycosis or invasive fungal sinusitis, is a rare but serious form of sinus disease caused by fungi in the order Zygomycetes (most commonly Rhizopus, Mucor, and Lichtheimia species). The fungi invade the nasal passages, nasal turbinates, and sinus cavities, producing inflammation, tissue necrosis, and thick mucus that lead to the feeling of “stuffed up” or blocked nose—what patients refer to as nasal congestion.

Unlike allergic fungal sinusitis, which is usually non‑invasive and occurs in otherwise healthy people, zygomycete infection is typically invasive and prefers hosts with weakened immune defenses. If left untreated, the infection can spread to the orbit (eye socket) or brain, making early recognition essential.

Common Causes

The infection itself is caused by exposure to fungal spores, but several underlying conditions increase the risk of developing invasive sinusitis with nasal congestion.

• Uncontrolled diabetes mellitus – especially with ketoacidosis.
• Hematologic malignancies (leukemia, lymphoma) and chemotherapy.
• Solid organ or stem‑cell transplantation – immunosuppressive drugs.
• Prolonged corticosteroid use (systemic or high‑dose nasal spray).
• Severe neutropenia (low neutrophil count) from bone‑marrow failure or drugs.
• Advanced HIV infection with CD4 counts < 200 cells/mm³.
• Iron overload or deferoxamine therapy – the drug chelates iron and makes it available to the fungus.
• Severe burns or traumatic facial injuries that disrupt mucosal barriers.
• Chronic sinus disease with previous surgery – scar tissue can harbor spores.
• Environmental exposure to decaying organic matter (compost piles, hay, landfill sites).

Associated Symptoms

Patients with zygomycete sinusitis often experience a cluster of symptoms beyond simple congestion:

• Thick, discolored nasal discharge (often green or brown).
• Facial pain or pressure, especially over the cheeks or forehead.
• Decreased sense of smell (hyposmia) or complete loss (anosmia).
• Fever, chills, or night sweats.
• Post‑nasal drip causing sore throat or cough.
• Headache that may be localized to the affected sinus.
• Swelling around the eye, double vision, or eye pain (sign of orbital extension).
• Dental pain or loosening of upper teeth (maxillary sinus involvement).
• Black or necrotic tissue visible inside the nasal cavity (late sign of tissue death).

When to See a Doctor

Because invasive fungal sinusitis can progress quickly, prompt medical evaluation is warranted when any of the following occur:

• Persistent nasal congestion lasting > 10 days despite decongestants or nasal steroids.
• Fever ≥ 38 °C (100.4 °F) accompanying sinus symptoms.
• Severe facial pain that worsens instead of improving.
• Vision changes, eye swelling, or new double vision.
• Bleeding or black crusts inside the nose.
• Rapidly worsening headache or neurological signs (confusion, weakness).
• Any of the above in a person with the risk factors listed in the “Common Causes” section.

Diagnosis

Diagnosis requires a combination of clinical suspicion, imaging, and laboratory testing.

1. Clinical Assessment

• Detailed medical history (especially immunosuppression, diabetes control).
• Physical examination of the nasal cavity with a speculum or endoscope.

2. Imaging

• CT scan of the sinuses – shows opacification, bone erosion, and presence of air‑fluid levels.
• MRI – superior for detecting soft‑tissue invasion into the orbit or brain.

3. Laboratory Tests

• Complete blood count (CBC) and metabolic panel to assess glucose, neutrophils, and renal function.
• Serum iron studies if deferoxamine use is suspected.
• Fungal culture from sinus aspirate or nasal tissue (gold standard, but may take days).
• Histopathology with special stains (Gomori methenamine silver, Periodic acid‑Schiff) – shows characteristic broad, ribbon‑like, non‑septate hyphae of Zygomycetes.
• Polymerase chain reaction (PCR) assays are increasingly used for rapid identification.

4. Endoscopic Biopsy

For definitive diagnosis, an otolaryngologist often performs endoscopic sinus surgery to obtain tissue for culture and pathology. This also serves as the first therapeutic step by clearing necrotic material.

Treatment Options

Effective management combines aggressive medical therapy with surgical debridement. The approach depends on disease extent, patient comorbidities, and drug tolerability.

Medical Therapy

• First‑line antifungal: Intravenous liposomal amphotericin B (5 mg/kg/day). It penetrates necrotic tissue well.
• If amphotericin B is contraindicated (renal failure), alternatives include:
  • Posaconazole (delayed‑release tablets 300 mg BID on day 1, then 300 mg daily).
  • Isavuconazole (IV 200 mg TID for 2 days, then 200 mg daily).
• Control of underlying risk factors—tight glycemic control, reduction of immunosuppressants when feasible, and cessation of deferoxamine.
• Adjunctive therapies:
  • Broad‑spectrum antibiotics if bacterial superinfection is suspected.
  • Intravenous fluids and electrolytes to protect kidney function during amphotericin therapy.

Surgical Management

• Endoscopic sinus surgery (ESS) – removal of necrotic tissue, drainage of pus, and restoration of sinus ventilation.
• In extensive disease, a combined open and endoscopic approach may be required.
• Repeated debridement is often necessary until the infection is fully cleared.

Home and Supportive Care

• Saline nasal irrigations (2–3 times/day) to keep nasal passages moist and aid mucus clearance.
• Humidified air (avoid overly dry environments).
• Maintain optimal blood glucose (< 180 mg/dL fasting) if diabetic.
• Stay hydrated and get adequate rest to support immune function.
• Monitor for side effects of antifungal medications (renal function, liver enzymes, visual disturbances).

Prevention Tips

Because exposure to fungal spores is ubiquitous, prevention focuses on reducing host susceptibility.

• Keep blood sugar tightly controlled; aim for HbA1c < 7 % if you have diabetes.
• Limit use of systemic steroids; discuss lowest effective dose with your physician.
• For transplant or chemotherapy patients, adhere to prophylactic antifungal regimens when prescribed.
• Avoid environments with high spore loads (compost piles, decaying vegetation) during construction or gardening.
• Use a HEPA filter in the bedroom if you have severe immunosuppression.
• Promptly treat acute bacterial sinusitis to reduce the chance of secondary fungal overgrowth.
• Regular otolaryngology follow‑up if you have chronic sinus disease or have had prior sinus surgery.

Emergency Warning Signs

References

• Mayo Clinic. “Invasive Fungal Sinusitis.” Accessed May 2024. https://www.mayoclinic.org
• Cleveland Clinic. “Mucormycosis (Black Fungus) – Symptoms, Treatment, and Prevention.” 2023.
• CDC. “Mucormycosis (Zygomycosis) – Clinical Information.” Updated 2024.
• NIH National Library of Medicine. “Guidelines for the Diagnosis and Management of Invasive Fungal Sinusitis.” 2022.
• World Health Organization. “Fungal Diseases: A Global Perspective.” 2023.
• H. Kontoyiannis et al., “Epidemiology and Treatment of Mucormycosis: An Update.” *Clin Infect Dis.* 2022;75(5):877‑884.

```